{"entity":{"id":"nct07050641","kind":"trial","name":"Phase I/II Study of SCTB39-1 in Advanced Solid Tumours","aka":[],"tldr":"A phase 1/2 trial of SCTB39-1 in advanced solid tumours, run by Sinocelltech Ltd., now recruiting.","summary":"Phase I/II Study of SCTB39-1 in Advanced Solid Tumours is a phase 1/2 interventional study registered as NCT07050641 by Sinocelltech Ltd., with 110 participants planned, started 2025-06-23 and due to reach its primary completion in 2028-06-30. Interventions recorded: SCTB39-1.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07050641","url":"https://clinicaltrials.gov/study/NCT07050641"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["sinocelltech"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07050641","phase":"1/2","setting":"An Open Multi-center Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCTB39-1 in Adult Patients With Advanced Malignant Solid Tumours","sponsor":"Sinocelltech Ltd.","enrolled":110,"outcomes":[]},"route":"/trials/nct07050641/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"sinocelltech","kind":"company","name":"Sinocelltech","route":"/companies/sinocelltech/"}]}}